Fundamental market expert SP Tulsian is upbeat on the pharma names like Aurobindo Pharma, Biocon and Divis Laboratories and Glenmark forabout 6-8 months or last one year. "In about 6-8 months Aurobindo Pharma had corrected a lot and given good value destruction to investors but time has come and the share may move to about Rs 750 in next 6 months. So there is an upside of about 25 percent from here going forward.”

Share Market Live

NSE

Giving his expert views in an interview with CNBC-TV18, he said they also have an extremely positive view on the cement stocks going forward. "Few cement stocks have already seen a good rise; JK Cement which was recommended at Rs 700 in February last year is now up 4-5 percent.”

Stating his rationale for being positive on Grasim he said there were talks that management was looking to increase the stake by about 5 percent in this financial year. If that happens then it would show the management's commitment towards the stock. "So positive on Grasim because all their divisions and subsidiaries are doing well now,” he added.

“In terms of relative returns, Manappuram Finance will be able to reach the target of Rs 195 in next one month or so. One could look at making a fresh buy in Manappuram but not in Muthoot Finance. However, Muthoot is an hold at the current levels."

Talking about Indian Railway Catering & Tourism Corp ( IRCTC), he said, "Even if I take FY21 estimates, the PE multiple for IRCTC works out at 40, so I won’t subscribe to the share with a PSU tag." The stock is a definite no at current valuation of around Rs 1800 he added.